bioAffinity Technologies prices USD 3.2 million public offering at USD 0.8 per share

bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

BIAF

0.00
  • bioAffinity Technologies priced a public offering expected to raise USD 3.2 million in gross proceeds.
  • Deal includes 4,000,000 common shares or pre-funded warrants at USD 0.8 per share or USD 0.793 per warrant.
  • Pre-funded warrants are immediately exercisable for one common share, expiring only when fully exercised.
  • Closing is expected on or about June 18, 2026, subject to customary closing conditions.
  • WallachBeth Capital is sole placement agent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260617929210) on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.